ARCHIVES

ODAC Rejects Temodal for Melanoma After Discussion Of Approval Standards

This article is from The Cancer Letter archive.

Vol. 25 No. 13 | April 2, 1999

Download PDF Visit The Full Archive

Related Articles

Biomedical Science Leadership is America’s Greatest Contribution, Benno Schmidt Says

August 14, 1987

Bush Budget Proposal a $511 Million Cut For NIH.

February 9, 2007

Support Available For Studies Abroad

August 12, 1983

Working Group Nears Agreement On New Core Grant Guidelines

January 16, 1981

Drug Cleared For GIST And Kidney Cancer, FDA’s First Two-Indication Cancer Approval

January 27, 2006

Smoking Conference Established Priorities

January 15, 1982